Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:09 PM
Ignite Modification Date:
2025-12-24 @ 10:09 PM
NCT ID:
NCT00812435
Eligibility Criteria:
Inclusion Criteria:
* Patients \>18 years old
* Patients with acute myocardial infarction whose symptom onset is within 12 hours of presentation
* ST-segment elevation 1 mm in 2 contiguous limb leads or 2 mm in 2 contiguous precordial leads
* Patients eligible for PCI
* Target lesion(s) in a native vessel
* Target lesion stenosis \>50% by angiography (visual estimate)
* Patients who are amenable to participating in study procedures and follow-up
* Patient or legal guardian has been informed and agrees to provide approved written informed consent and data privacy authorization
Exclusion Criteria:
* Patients with cardiogenic shock (SBP\<80 mmHg for \>30 minutes or requiring pressors or IABP due to hypotension)
* Patients with cardiac arrest at any point prior to intervention (within the preceeding 24 hours)
* Patients on chronic warfarin (Coumadin) therapy
* Patients with known bleeding diathesis or active bleeding at the time of presentation to the catheterization laboratory
* Patients with known bleeding diathesis or active bleeding within prior 3 months
* Patients who receive thrombolytic therapy or glycoprotein IIb/IIIa inhibitors prior to PCI (within the preceding 8 hours)
* Patients with a platelet count \<100,000 cells/mm3 within the preceeding 7 days
* Patients with known allergies to aspirin, clopidogrel bisulfate (Plavix), heparin, bivalirudin, glycoprotein IIb/IIIa inhibitors or intravenous contrast dye that cannot be medically managed
* Patients with major surgery within the past 6 months or scheduled surgery within 6 weeks
* Patients with significant unprotected left main disease (stenosis \>60%) or with multivessel coronary disease that will require emergent coronary artery bypass surgery
* Patients with TIA or CVA within the past 30 days or any history of hemorrhagic stroke
* Patients who have undergone PCI within the preceding 30 days prior to enrollment
* Patients with known impaired renal function
* Patient is know to be pregnant or lactating
* Patients with active participation in another device or drug study
* Patients with comorbidities conferring a life expectancy of less than a year
* Patients with left bundle branch block
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00812435
Study Brief:
Protocol Section:
NCT00812435